ERBB3 and cancer: Furthermore, a preclinical study found that the HER3 vaccine antibody and HER3 peptide mimetic could inhibit cancer cell proliferation and receptor phosphorylation and induce apoptosis and antibody-dependent cytotoxicity [130].